Literature DB >> 24126470

Symptom changes in five dimensions of the Positive and Negative Syndrome Scale in refractory psychosis.

Todd S Woodward1, Kwanghee Jung, Geoffrey N Smith, Heungsun Hwang, Alasdair M Barr, Ric M Procyshyn, Sean W Flynn, Mark van der Gaag, William G Honer.   

Abstract

Refractory psychosis units currently have little information regarding which symptoms profiles should be expected to respond to treatment. In the current study, we provide this information using structural equation modeling of Positive and Negative Syndrome Scale (PANSS) ratings at admission and discharge on a sample of 610 patients admitted to a treatment refractory psychosis program at a Canadian tertiary care unit between 1990 and 2011. The hypothesized five-dimensional structure of the PANSS fit the data well at both admission and discharge, and the latent variable scores are reported as a function of symptom dimension and diagnostic category. The results suggest that, overall, positive symptoms (POS) responded to treatment better than all other symptoms dimensions, but for the schizoaffective and bipolar groups, greater response on POS was observed relative to the schizophrenia and major depression groups. The major depression group showed the most improvement on negative symptoms and emotional distress, and the bipolar group showed the most improvement on disorganization. Schizophrenia was distinct from schizoaffective disorder in showing reduced treatment response on all symptom dimensions. These results can assist refractory psychosis units by providing information on how PANSS symptom dimensions respond to treatment and how this depends on diagnostic category.

Entities:  

Mesh:

Year:  2013        PMID: 24126470     DOI: 10.1007/s00406-013-0460-x

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  32 in total

1.  Treatment refractory schizophrenia.

Authors:  J P Lindenmayer
Journal:  Psychiatr Q       Date:  2000

2.  The five-factor model of the Positive and Negative Syndrome Scale II: a ten-fold cross-validation of a revised model.

Authors:  Mark van der Gaag; Tonko Hoffman; Mila Remijsen; Ron Hijman; Lieuwe de Haan; Berno van Meijel; Peter N van Harten; Lucia Valmaggia; Marc de Hert; Anke Cuijpers; Durk Wiersma
Journal:  Schizophr Res       Date:  2006-05-26       Impact factor: 4.939

3.  Predictability of rehospitalisation over 5 years for schizophrenia, bipolar disorder and depression.

Authors:  B A Daniels; K C Kirkby; D A Hay; B J Mowry; I H Jones
Journal:  Aust N Z J Psychiatry       Date:  1998-04       Impact factor: 5.744

4.  The Positive and Negative Syndrome Scale (PANSS): rationale and standardisation.

Authors:  S R Kay; L A Opler; J P Lindenmayer
Journal:  Br J Psychiatry Suppl       Date:  1989-11

5.  A latent variable framework for modeling dyadic measures in research on shared decision-making.

Authors:  Levente Kriston; Martin Härter; Isabelle Scholl
Journal:  Z Evid Fortbild Qual Gesundhwes       Date:  2012-04-23

6.  Stability of the five-factor structure of the Positive and Negative Syndrome Scale (PANSS).

Authors:  C Lançon; P Auquier; G Nayt; G Reine
Journal:  Schizophr Res       Date:  2000-05-05       Impact factor: 4.939

Review 7.  Remission in schizophrenia: proposed criteria and rationale for consensus.

Authors:  Nancy C Andreasen; William T Carpenter; John M Kane; Robert A Lasser; Stephen R Marder; Daniel R Weinberger
Journal:  Am J Psychiatry       Date:  2005-03       Impact factor: 18.112

8.  Diagnostic confusion in treatment-refractory psychotic patients.

Authors:  G N Smith; G W MacEwan; R J Ancill; W G Honer; T S Ehmann
Journal:  J Clin Psychiatry       Date:  1992-06       Impact factor: 4.384

Review 9.  Emerging drugs for schizophrenia.

Authors:  Ofer Agid; Shitij Kapur; Gary Remington
Journal:  Expert Opin Emerg Drugs       Date:  2008-09       Impact factor: 4.191

10.  Mechanism of the antipsychotic effect in the treatment of acute schizophrenia.

Authors:  E C Johnstone; T J Crow; C D Frith; M W Carney; J S Price
Journal:  Lancet       Date:  1978-04-22       Impact factor: 79.321

View more
  7 in total

1.  New aspects of cognition domains and psychopathological measures in psychiatry.

Authors:  Daniela Reich-Erkelenz; Andrea Schmitt; Peter Falkai
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-12       Impact factor: 5.270

2.  Affective symptom dimensions in early-onset psychosis over time: a principal component factor analysis of the Young Mania Rating Scale and the Hamilton Depression Rating Scale.

Authors:  Marta Rapado-Castro; Carmen Moreno; Gonzalo Salazar de Pablo; Dolores Moreno; Ana Gonzalez-Pinto; Beatriz Paya; Josefina Castro-Fonieles; Inmaculada Baeza; Montserrat Graell; Celso Arango
Journal:  Eur Child Adolesc Psychiatry       Date:  2021-05-30       Impact factor: 4.785

Review 3.  Focus on psychosis.

Authors:  Wolfgang Gaebel; Jürgen Zielasek
Journal:  Dialogues Clin Neurosci       Date:  2015-03       Impact factor: 5.986

4.  Antipsychotic prescribing patterns on admission to and at discharge from a tertiary care program for treatment-resistant psychosis.

Authors:  Lik Hang N Lee; Ric M Procyshyn; Randall F White; Todd S Woodward; William G Honer; Alasdair M Barr
Journal:  PLoS One       Date:  2018-08-10       Impact factor: 3.240

5.  Symptom dimensions of the psychotic symptom rating scales in psychosis: a multisite study.

Authors:  Todd S Woodward; Kwanghee Jung; Heungsun Hwang; John Yin; Laura Taylor; Mahesh Menon; Emmanuelle Peters; Elizabeth Kuipers; Flavie Waters; Tania Lecomte; Iris E Sommer; Kirstin Daalman; Remko van Lutterveld; Daniela Hubl; Jochen Kindler; Philipp Homan; Johanna C Badcock; Saruchi Chhabra; Matteo Cella; Sarah Keedy; Paul Allen; Andrea Mechelli; Antonio Preti; Sara Siddi; David Erickson
Journal:  Schizophr Bull       Date:  2014-07       Impact factor: 9.306

6.  Clinical outcomes in individuals at clinical high risk of psychosis who do not transition to psychosis: a meta-analysis.

Authors:  Gonzalo Salazar de Pablo; Livia Soardo; Anna Cabras; Joana Pereira; Simi Kaur; Filippo Besana; Vincenzo Arienti; Francesco Coronelli; Jae Il Shin; Marco Solmi; Natalia Petros; Andre F Carvalho; Philip McGuire; Paolo Fusar-Poli
Journal:  Epidemiol Psychiatr Sci       Date:  2022-01-19       Impact factor: 6.892

7.  Longitudinal outcome of attenuated positive symptoms, negative symptoms, functioning and remission in people at clinical high risk for psychosis: a meta-analysis.

Authors:  Gonzalo Salazar de Pablo; Filippo Besana; Vincenzo Arienti; Ana Catalan; Julio Vaquerizo-Serrano; Anna Cabras; Joana Pereira; Livia Soardo; Francesco Coronelli; Simi Kaur; Josette da Silva; Dominic Oliver; Natalia Petros; Carmen Moreno; Ana Gonzalez-Pinto; Covadonga M Díaz-Caneja; Jae Il Shin; Pierluigi Politi; Marco Solmi; Renato Borgatti; Martina Maria Mensi; Celso Arango; Christoph U Correll; Philip McGuire; Paolo Fusar-Poli
Journal:  EClinicalMedicine       Date:  2021-06-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.